1 Hypovitaminosis A from inadequate vitA intake causes hai
2 ounts for poor antibody-mediated immunity in
hypovitaminosis A, since IFN-gamma in relatively small a
3 Hypovitaminosis C and D are highly prevalent in acute-ca
4 pitalized patients with a high prevalence of
hypovitaminosis C and D.
5 pitalized patients with a high prevalence of
hypovitaminosis C and D.
6 Subjects with
hypovitaminosis D (<20 ng/mL) had a greater prevalence o
7 metabolic syndrome than did subjects without
hypovitaminosis D (30% compared with 11%; P = 0.0076).
8 Reports of
hypovitaminosis D among adults in the United States have
9 examined the prevalence and determinants of
hypovitaminosis D among African American and white women
10 The high prevalence of
hypovitaminosis D among African American women warrants
11 National data on
hypovitaminosis D among children are not yet available.
12 The determinants of
hypovitaminosis D among women should be considered when
13 There was no association between
hypovitaminosis D and either bone mineral density (P = 0
14 Reports of a high prevalence of
hypovitaminosis D and its association with increased ris
15 aviolet-light exposure, and risk factors for
hypovitaminosis D and measured serum 25-hydroxyvitamin D
16 The causal nature of the association between
hypovitaminosis D and poor cognitive function in mid- to
17 Hypovitaminosis D and reduced IGF-1 are associated, indi
18 by environmental factors such as pathogens,
hypovitaminosis D and smoking, may be a critical initiat
19 Subjects with
hypovitaminosis D are at higher risk of insulin resistan
20 bjects with vitamin D deficiency, those with
hypovitaminosis D had a 7.3% higher BMD (adjusted percen
21 Although
hypovitaminosis D has been detected frequently in elderl
22 In apparent contrast,
hypovitaminosis D has been reported in patients with pri
23 ebound status were independent predictors of
hypovitaminosis D in a multivariate model.
24 mined the prevalence of and risk factors for
hypovitaminosis D in children, adolescents, and young ad
25 has led to concerns about the prevalence of
hypovitaminosis D in many parts of the world.
26 We observed a high incidence of
hypovitaminosis D in patients with IBD.
27 Prevalence of
hypovitaminosis D in the general population was alarming
28 We aimed to determine the prevalence of
hypovitaminosis D in the white British population and to
29 ut few studies have examined determinants of
hypovitaminosis D in this population.
30 Hypovitaminosis D is associated with many features of th
31 Hypovitaminosis D is common in general medical inpatient
32 Hypovitaminosis D is prevalent among individuals with ga
33 Hypovitaminosis D may be a risk factor for lung dysfunct
34 ating epidemiological evidence suggests that
hypovitaminosis D may be associated with type 2 diabetes
35 insulin sensitivity and a negative effect of
hypovitaminosis D on beta cell function.
36 f the patients, and 58% of the patients with
hypovitaminosis D presented with delayed bone mineraliza
37 The prevalence of
hypovitaminosis D was 42.4 +/- 3.1% ( +/- SE) among Afri
38 Hypovitaminosis D was associated with noninfectious uvei
39 n this sample of pediatric patients with CD,
hypovitaminosis D was common and was associated with the
40 Hypovitaminosis D was defined as a serum 25-hydroxyvitam
41 Hypovitaminosis D was defined as a serum concentration o
42 ia, 26% presented with hypophosphatemia, and
hypovitaminosis D was detected in 63%.
43 The prevalence of
hypovitaminosis D was highest during the winter and spri
44 Among African Americans,
hypovitaminosis D was independently associated with cons
45 Hypovitaminosis D was most prevalent during the winter (
46 Hypovitaminosis D was observed in 55.14% of patients wit
47 Vitamin D deficiency (
hypovitaminosis D) causes osteomalacia and poor long bon
48 0 nmol/L, which is considered deficient (ie,
hypovitaminosis D).
49 5(OH)D levels 16-32 ng/ml were classified as
hypovitaminosis D, and 25(OH)D levels >32 ng/ml were cla
50 duals, 15% were vitamin D deficient, 51% had
hypovitaminosis D, and 34% were vitamin D replete.
51 Persistence of hyperparathyroidism,
hypovitaminosis D, and immunosuppressive drugs may have
52 on practices are not effective in preventing
hypovitaminosis D, particularly among vulnerable populat
53 years of age without known risk factors for
hypovitaminosis D, the prevalence of vitamin D deficienc
54 icacy of this approach in the elimination of
hypovitaminosis D, which is a widespread health disparit
55 ith IGF-1 was found only among those without
hypovitaminosis D.
56 om supplements (200 IU/d), 28.2 +/- 2.7% had
hypovitaminosis D.
57 demographic, and behavioral determinants of
hypovitaminosis D.
58 16% (95% CI: 9.3%, 23%) of the subjects had
hypovitaminosis D.
59 en and 20% of women, and 15% of patients had
hypovitaminosis D.
60 in were significant univariate predictors of
hypovitaminosis D.